Precipio Inc (PRPO)

$27.88 +0.95 (3.53%)
Market Cap 50.04M
Revenue (ttm) 18.53M
Net Income (ttm) -4.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -23.15%
Debt to Equity Ratio 0.01
Volume 19,000
Avg Vol 16,354
Day's Range N/A - N/A
Shares Out 1.75M
Stochastic %K 56%
Beta 1.22
Analysts Strong Buy
Price Target $40.00

Company Profile

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Hav...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 203 787 7888
Address:
4 Science Park, 3rd Floor, New Haven, United States
imatisse
imatisse Mar. 20 at 12:53 PM
$PRPO Cancer diagnostics firm's preliminary Q4 revenue rises 23% yr/yr to $6.7 mln Adjusted EBITDA for Q4-2025 reaches $0.95 mln, showing significant improvement Company reports positive operating cash flow for Q4-2025, excluding unusual items
0 · Reply
Awaywithshorts
Awaywithshorts Mar. 20 at 10:48 AM
$PRPO Should be 60+ all day long
0 · Reply
Loren77
Loren77 Mar. 19 at 3:15 PM
$PRPO this shit is very very strong now
0 · Reply
Loren77
Loren77 Mar. 18 at 3:27 PM
$PRPO no volume.. buyers have to push the price
0 · Reply
Messi0321
Messi0321 Mar. 17 at 9:39 PM
$PRPO based on price action, somebody knows something. My guess is there will be some prs before call, i just dont know what date they will release. Not this week for sure considering no news up until now. Maube next week.
0 · Reply
eddiel
eddiel Mar. 17 at 6:18 PM
$PRPO Very close to 30 now !
0 · Reply
Matt812
Matt812 Mar. 16 at 5:57 PM
$PRPO Prpo and proud
0 · Reply
SinnagodKosher
SinnagodKosher Mar. 13 at 4:56 PM
$PRPO one step back today, twenty five steps forward next week.
0 · Reply
Messi0321
Messi0321 Mar. 12 at 10:21 PM
$PRPO so earning call is on 2nd of april, when do u guys think they will release some news/pr before it? If they release it. I personally think it will next or week after that, because they dont wanno do call in middle of volalite days right after release. Any opinions guys?
1 · Reply
Bader0555
Bader0555 Mar. 12 at 3:37 PM
$PRPO During today's trading session, the annual price exceeded its highest level.
1 · Reply
Latest News on PRPO
Precipio Announces Q4 and year-end 2025 Shareholder Update Call

Mar 12, 2026, 5:00 PM EDT - 9 days ago

Precipio Announces Q4 and year-end 2025 Shareholder Update Call

Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year

Feb 25, 2026, 9:30 AM EST - 24 days ago

Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year

Precipio Takes Major Steps Toward a Clean Balance Sheet

Jan 15, 2026, 9:00 AM EST - 2 months ago

Precipio Takes Major Steps Toward a Clean Balance Sheet

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

Dec 5, 2025, 10:00 AM EST - 3 months ago

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

Dec 4, 2025, 8:00 AM EST - 3 months ago

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

Precipio Announces its Q3-2025 Financial Results

Nov 14, 2025, 4:30 PM EST - 4 months ago

Precipio Announces its Q3-2025 Financial Results

Precipio Announces Q3-2025 Shareholder Update Call

Nov 4, 2025, 5:00 PM EST - 4 months ago

Precipio Announces Q3-2025 Shareholder Update Call

Precipio Announces its Q2-2025 Financial Results

Aug 13, 2025, 5:00 PM EDT - 7 months ago

Precipio Announces its Q2-2025 Financial Results

Precipio Announces Q2-2025 Shareholder Update Call

Jul 31, 2025, 4:30 PM EDT - 8 months ago

Precipio Announces Q2-2025 Shareholder Update Call

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Jul 11, 2025, 4:30 PM EDT - 9 months ago

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Precipio Announces its Q1-2025 Financial Results

May 14, 2025, 5:00 PM EDT - 11 months ago

Precipio Announces its Q1-2025 Financial Results

Precipio Announces Q1-2025 Shareholder Update Call

May 1, 2025, 5:00 PM EDT - 11 months ago

Precipio Announces Q1-2025 Shareholder Update Call

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Mar 17, 2025, 5:00 PM EDT - 1 year ago

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Feb 25, 2025, 9:30 AM EST - 1 year ago

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Jan 16, 2025, 5:00 PM EST - 1 year ago

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Precipio Announces Q3-2024 Shareholder Update Call

Nov 6, 2024, 5:00 PM EST - 1 year ago

Precipio Announces Q3-2024 Shareholder Update Call

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Oct 8, 2024, 10:00 AM EDT - 1 year ago

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Precipio Announces Employee Stock Option Plan Repricing

Sep 6, 2024, 4:00 PM EDT - 1 year ago

Precipio Announces Employee Stock Option Plan Repricing

Precipio Announces Q2-2024 Shareholder Update Call

Aug 15, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Q2-2024 Shareholder Update Call

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Jun 13, 2024, 4:00 PM EDT - 1 year ago

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Jun 12, 2024, 4:00 PM EDT - 1 year ago

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Precipio Secures a short-term $500K Credit Facility

May 6, 2024, 5:00 PM EDT - 2 years ago

Precipio Secures a short-term $500K Credit Facility

Precipio Announces Year end 2023 Shareholder Update Call

Mar 25, 2024, 5:00 PM EDT - 2 years ago

Precipio Announces Year end 2023 Shareholder Update Call

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Feb 13, 2024, 10:00 AM EST - 2 years ago

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Feb 6, 2024, 10:00 AM EST - 2 years ago

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Jan 23, 2024, 10:00 AM EST - 2 years ago

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Jan 17, 2024, 10:30 AM EST - 2 years ago

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Precipio Announces Christina Valauri joins the Board of Directors

Jan 2, 2024, 9:00 AM EST - 2 years ago

Precipio Announces Christina Valauri joins the Board of Directors

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Dec 14, 2023, 4:30 PM EST - 2 years ago

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Precipio Announces Q3-2023 Shareholder Update Call

Nov 16, 2023, 5:00 PM EST - 2 years ago

Precipio Announces Q3-2023 Shareholder Update Call

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Oct 18, 2023, 9:00 AM EDT - 2 years ago

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Oct 3, 2023, 10:00 AM EDT - 2 years ago

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Precipio Continues to Sign New HemeScreen™ Customers

Sep 28, 2023, 9:00 AM EDT - 2 years ago

Precipio Continues to Sign New HemeScreen™ Customers

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Sep 25, 2023, 11:00 AM EDT - 2 years ago

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Sep 21, 2023, 9:00 AM EDT - 2 years ago

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Sep 13, 2023, 9:30 AM EDT - 2 years ago

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Precipio Announces Q2-2023 Shareholder Update Call

Aug 10, 2023, 5:00 PM EDT - 2 years ago

Precipio Announces Q2-2023 Shareholder Update Call

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Aug 8, 2023, 9:00 AM EDT - 2 years ago

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Aug 3, 2023, 9:00 AM EDT - 2 years ago

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Aug 1, 2023, 9:00 AM EDT - 2 years ago

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Jun 14, 2023, 9:49 AM EDT - 3 years ago

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Jun 13, 2023, 9:00 AM EDT - 3 years ago

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Jun 8, 2023, 8:30 AM EDT - 3 years ago

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

Jun 7, 2023, 9:30 AM EDT - 3 years ago

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

May 22, 2023, 11:00 AM EDT - 3 years ago

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

Precipio Shares Growth Catalysts For HemeScreen

May 17, 2023, 4:00 PM EDT - 3 years ago

Precipio Shares Growth Catalysts For HemeScreen

Precipio Announces Q1-2023 Shareholder Update Call

May 15, 2023, 4:00 PM EDT - 3 years ago

Precipio Announces Q1-2023 Shareholder Update Call

Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division

May 4, 2023, 1:00 PM EDT - 3 years ago

Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division

imatisse
imatisse Mar. 20 at 12:53 PM
$PRPO Cancer diagnostics firm's preliminary Q4 revenue rises 23% yr/yr to $6.7 mln Adjusted EBITDA for Q4-2025 reaches $0.95 mln, showing significant improvement Company reports positive operating cash flow for Q4-2025, excluding unusual items
0 · Reply
Awaywithshorts
Awaywithshorts Mar. 20 at 10:48 AM
$PRPO Should be 60+ all day long
0 · Reply
Loren77
Loren77 Mar. 19 at 3:15 PM
$PRPO this shit is very very strong now
0 · Reply
Loren77
Loren77 Mar. 18 at 3:27 PM
$PRPO no volume.. buyers have to push the price
0 · Reply
Messi0321
Messi0321 Mar. 17 at 9:39 PM
$PRPO based on price action, somebody knows something. My guess is there will be some prs before call, i just dont know what date they will release. Not this week for sure considering no news up until now. Maube next week.
0 · Reply
eddiel
eddiel Mar. 17 at 6:18 PM
$PRPO Very close to 30 now !
0 · Reply
Matt812
Matt812 Mar. 16 at 5:57 PM
$PRPO Prpo and proud
0 · Reply
SinnagodKosher
SinnagodKosher Mar. 13 at 4:56 PM
$PRPO one step back today, twenty five steps forward next week.
0 · Reply
Messi0321
Messi0321 Mar. 12 at 10:21 PM
$PRPO so earning call is on 2nd of april, when do u guys think they will release some news/pr before it? If they release it. I personally think it will next or week after that, because they dont wanno do call in middle of volalite days right after release. Any opinions guys?
1 · Reply
Bader0555
Bader0555 Mar. 12 at 3:37 PM
$PRPO During today's trading session, the annual price exceeded its highest level.
1 · Reply
Loren77
Loren77 Mar. 12 at 1:02 PM
$PRPO market cap 49M , are you kidding me? It's still a penny stock. The market has yet to properly value it.
0 · Reply
Loren77
Loren77 Mar. 12 at 12:55 PM
$PRPO with or withouth news.. accumulation is coming to an end. 30+ 40+ 50+ .. and so on
0 · Reply
Zufam
Zufam Mar. 12 at 2:27 AM
$PRPO
0 · Reply
Messi0321
Messi0321 Mar. 11 at 9:46 PM
$PRPO cmoooon baby, give us some boooom shakalaka 😄. Gas getting expensive folks, this war is about to drag on months now. Hyperinflation is cming, health sector is one the kinda flourishes during war time btw.
0 · Reply
Bader0555
Bader0555 Mar. 11 at 8:45 PM
$PRPO He will be very active, keep a close eye on him.
0 · Reply
DT1987
DT1987 Mar. 11 at 7:57 PM
$PRPO incoming new 52wk high
0 · Reply
Awaywithshorts
Awaywithshorts Mar. 11 at 5:38 PM
$PRPO
0 · Reply
Loren77
Loren77 Mar. 11 at 4:39 PM
$PRPO waiting for.. 🚀 strong breakout soon
0 · Reply
imatisse
imatisse Mar. 10 at 2:44 PM
$PRPO $40
0 · Reply
DARKP00L
DARKP00L Mar. 10 at 1:11 PM
$PRPO 09:05 on Mar. 10 2026 Precipio Announces Data On New Bloodhound Assay For Chronic Myeloid Leukemia Published In Journal Of Clinical Pathology #tradeideas
0 · Reply
Hellroaring
Hellroaring Mar. 10 at 1:05 PM
$PRPO ~ Nice PR 👍
0 · Reply
SinnagodKosher
SinnagodKosher Mar. 9 at 6:56 PM
$PRPO this drop is NOTHING 😤👍🏼🆙
0 · Reply